Reading in an announcement from another biotech company that there is big delays in getting medical devices approved in the EU due to new regulations. I don’t believe there is any problems with the IMR approval process but rather there is just such a big back log.
All this really means is revenue will be delayed. Could be a buying opportunity from impatient people.
Reading in an announcement from another biotech company that...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.050(3.16%) |
Mkt cap ! $490.2M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.58 | $1.51 | $621.4K | 405.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3058 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 1638 | 4 |
View Market Depth
| Last trade - 15.19pm 17/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |